Home/Filings/4/0001209191-18-001005
4//SEC Filing

Lafond Kevin G 4

Accession 0001209191-18-001005

CIK 0001107421other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:57 PM ET

Size

8.2 KB

Accession

0001209191-18-001005

Insider Transaction Report

Form 4
Period: 2017-12-29
Lafond Kevin G
Vice Pres., Treasurer, & CAO
Transactions
  • Award

    Common Stock

    2017-12-29+53,000110,967 total
  • Tax Payment

    Common Stock

    2017-12-30$4.14/sh13,100$54,23497,867 total
  • Tax Payment

    Common Stock

    2017-12-31$4.14/sh9,333$38,63988,534 total
Footnotes (2)
  • [F1]17,666 shares shall vest on 12/29/2018; 17,667 shares shall vest on each of 12/29/2019 and 12/29/2020.
  • [F2]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001429559

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:57 PM ET
Size
8.2 KB